Citation Impact
Citing Papers
Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression
2010
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?
2015
Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors
2022
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Mast cell progenitors: Origin, development and migration to tissues
2014
M1-like macrophage polarization prevails in young children with classic Hodgkin Lymphoma from Argentina
2019
Cancer statistics, 2020
2020 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Mast Cells
2008
Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed–Sternberg cell
2007
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
2009
TT Viruses: Oncogenic or Tumor-Suppressive Properties?
2008 StandoutNobel
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Phenol‐Soluble Modulin α3 Enhances the Human Neutrophil Lysis Mediated by Panton‐Valentine Leukocidin
2009
Factors Associated with the Outcome of Life-Threatening Necrotizing Pneumonia due to Community-Acquired <i>Staphylococcus aureus</i> in Adult and Adolescent Patients
2010
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
Macrophages in immunoregulation and therapeutics
2023 Standout
The human keratins: biology and pathology
2008 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
IgE and mast cells in allergic disease
2012 Standout
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Involvement of eosinophils in the anti-tumor response
2012
Mast cells and angiogenesis
2002
Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community
2008
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Angiogenesis in health and disease
2003 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
2018
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group
2013 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Oncogenic Activation of NF- B
2010
The immunology of stroke: from mechanisms to translation
2011 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Factors Predicting Mortality in Necrotizing Community-Acquired Pneumonia Caused by Staphylococcus aureus Containing Panton-Valentine Leukocidin
2007
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review
2013 Standout
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Clinical utility of cytokeratins as tumor markers
2004
Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes
2013
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial
2011
Gene expression perturbation in vitro—A growing case for three-dimensional (3D) culture systems
2005
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Contribution of the Epstein–Barr virus to the molecular pathogenesis of Hodgkin lymphoma
2007
Macrophage M1/M2 polarization
2020 Standout
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Cancer and the chemokine network
2004 Standout
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
The significant role of mast cells in cancer
2011
Liquid Biopsies and Cancer Immunotherapy
2018
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences
2018
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Hydrogels as extracellular matrix mimics for 3D cell culture
2009 Standout
Differentiation and Immune Regulation of IL-9−Producing CD4 + T Cells in Malignant Pleural Effusion
2012
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Hodgkin lymphoma: 2018 update on diagnosis, risk‐stratification, and management
2018
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma
2017
Characterization of CD30/CD30L+Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis
2015
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Phase I Trial of a CD8+T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis
2007
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
2017
Wound Healing: A Cellular Perspective
2018 Standout
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
2018
Mast Cells Enhance T Cell Activation: Importance of Mast Cell Costimulatory Molecules and Secreted TNF
2006
TCR-Independent CD30 Signaling Selectively Induces IL-13 Production Via a TNF Receptor-Associated Factor/p38 Mitogen-Activated Protein Kinase-Dependent Mechanism
2002
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
The role of cytokines in classical Hodgkin lymphoma
2002
Thymidylate Synthase Expression and Prognosis in Colorectal Cancer: A Systematic Review and Meta-Analysis
2004
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma
2018
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Daniel Molin being referenced
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
2017
Bystander Cells and Prognosis in Hodgkin Lymphoma
2004
Tumour markers as early predictors of response to chemotherapy in advanced colorectal carcinoma
2002
Community-acquired pneumonia and bacteraemia in a healthy young woman caused by methicillin-resistant Staphylococcus aureus (MRSA) carrying the genes encoding Panton-Valentine leukocidin (PVL)
2005
Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma
2003
Mast cell infiltration is a favourable prognostic factor in diffuse large B‐cell lymphoma
2007
Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma
2002
Mast cells express functional CD30 ligand and are the predominant CD30L‐positive cells in Hodgkin's disease
2001
Pembrolizumab in Relapsed/Refractory Classical Hodgkin Lymphoma: Primary End Point Analysis of the Phase 2 Keynote-087 Study
2016
The role of tumour‐infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children
2016
Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma
2007
Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma.
2003
Thymidylate synthase and p53 expression do not predict chemotherapy outcome in metastatic colorectal carcinoma
2001